Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Scorpius offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and ...

The Reverse Stock Split will take legal effect at 12:01 A.M. Eastern Time on January 21, 2025, and the Company's Common Stock will open for trading on the NYSE American on January 21, 2025, on a ...

Scorpius Holdings, Inc (NYSE American:SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced its collaboration with KaloCyte, ...

This collaboration underscores Scorpius’ reputation as a trusted partner for biomanufacturing at all stages of development. With state-of-the-art facilities in San Antonio, TX, and a team of ...